SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000898430-02-003028
Filing Date
2002-08-13
Accepted
2002-08-13 16:08:37
Documents
13
Period of Report
2002-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q, FOR QUARTERLY PERIOD ENDED JUNE 30,2002 d10q.htm 10-Q 442129
3 AMENDED AND RESTATED BYLAWS OF AMGEN INC. dex32.htm EX-3.2 88890
4 SPECIAL SEVERANCE PAY PLAN dex1040.htm EX-10.40 58385
5 AMENDMENT NO. 2 TO ENBREL SUPPLY AGREEMENT dex1077.htm EX-10.77 49918
6 ASSET PURCHASE AGREEMENT dex1078.htm EX-10.78 408150
7 AMENDMENT NO.1 TO ASSET PURCHASE AGREEMENT dex1079.htm EX-10.79 11870
8 AMENDMENT NO. 2 TO ASSET PURCHASE AGREEMENT dex1080.htm EX-10.80 55504
9 PROMISSORY NOTE dex1081.htm EX-10.81 17295
10 EMPLOYMENT AGREEMENT dex1082.htm EX-10.82 72134
11 RESTRICTED STOCK PURCHASE AGREEMENT dex1083.htm EX-10.83 20713
12 STOCK OPTION AGREEMENT dex1084.htm EX-10.84 15395
13 AGREEMENT BETWEEN AMGEN AND DR. DOUGLAS WILLIAMS dex1085.htm EX-10.85 14046
14 PROMISSORY NOTE dex1086.htm EX-10.86 17528
  Complete submission text file 0000898430-02-003028.txt   1275186
Mailing Address ONE AMGEN CENTER DRIVE MAIL STOP 27-3-C THOUSAND OAKS CA 91320-1799
Business Address ONE AMGEN CENTER DRIVE THOUSAND OAKS CA 91320-1799 805-447-1000
AMGEN INC (Filer) CIK: 0000318154 (see all company filings)

IRS No.: 953540776 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-12477 | Film No.: 02729819
SIC: 2836 Biological Products, (No Diagnostic Substances)